Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
55.96
-0.23 (-0.41%)
Nov 13, 2024, 4:00 PM EST - Market closed
Cytokinetics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -576.4 | -526.24 | -388.96 | -215.31 | -127.29 | -121.69 | Upgrade
|
| Depreciation & Amortization | 13.48 | 11.89 | 5.81 | 2.28 | 1.83 | 1.29 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 2.84 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 0.04 | 0.11 | - | -0.57 | - | Upgrade
|
| Stock-Based Compensation | 91.08 | 72.07 | 47.85 | 26.83 | 17.62 | 10.76 | Upgrade
|
| Other Operating Activities | 28.66 | 24.83 | 60.37 | 32.38 | 32.46 | 22.62 | Upgrade
|
| Change in Accounts Receivable | 2.26 | -1.14 | 56.67 | -47.4 | 0.74 | 1.62 | Upgrade
|
| Change in Accounts Payable | -2.68 | -3.48 | 4.52 | 1.06 | -0.11 | 4.4 | Upgrade
|
| Change in Unearned Revenue | - | - | -87 | - | 87 | - | Upgrade
|
| Change in Other Net Operating Assets | 39.25 | 7.71 | 1.1 | 54.8 | -2.74 | -9.91 | Upgrade
|
| Operating Cash Flow | -404.36 | -414.33 | -299.52 | -142.52 | 8.94 | -90.91 | Upgrade
|
| Capital Expenditures | -2.69 | -1.42 | -11.34 | -48.87 | -11.05 | -2.62 | Upgrade
|
| Investment in Securities | -742.68 | 240.67 | -250.8 | -98.91 | -185.46 | -72.09 | Upgrade
|
| Investing Cash Flow | -745.37 | 239.25 | -262.13 | -147.78 | -196.52 | -74.71 | Upgrade
|
| Long-Term Debt Issued | - | - | 523.59 | - | - | 135.57 | Upgrade
|
| Long-Term Debt Repaid | - | -0.86 | -188.93 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -6.93 | -0.86 | 334.66 | - | - | 135.57 | Upgrade
|
| Issuance of Common Stock | 922.4 | 182.69 | 17.54 | 324.85 | 234.23 | 37.61 | Upgrade
|
| Repurchase of Common Stock | -18.45 | -10.52 | -9.6 | -4.87 | -2.26 | - | Upgrade
|
| Other Financing Activities | 200 | 50 | 173.56 | - | 2.15 | -13.39 | Upgrade
|
| Financing Cash Flow | 1,097 | 221.32 | 516.17 | 319.98 | 234.12 | 159.79 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.1 | -0.02 | - | - | - | - | Upgrade
|
| Net Cash Flow | -52.8 | 46.22 | -45.48 | 29.68 | 46.55 | -5.82 | Upgrade
|
| Free Cash Flow | -407.05 | -415.75 | -310.85 | -191.39 | -2.11 | -93.53 | Upgrade
|
| Free Cash Flow Margin | -12645.23% | -5521.24% | -328.64% | -271.76% | -3.78% | -348.09% | Upgrade
|
| Free Cash Flow Per Share | -3.80 | -4.31 | -3.46 | -2.49 | -0.03 | -1.62 | Upgrade
|
| Cash Interest Paid | 25.65 | 10.3 | 15.17 | 9.18 | 9.62 | 4.06 | Upgrade
|
| Levered Free Cash Flow | -242.42 | -261.36 | -127.01 | -179.83 | -69 | -67.34 | Upgrade
|
| Unlevered Free Cash Flow | -191.81 | -225.32 | -95.04 | -161.5 | -44.83 | -50.24 | Upgrade
|
| Change in Net Working Capital | -34.22 | -2.27 | -65.26 | 25.29 | -5.49 | -2.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.